Modern foods in the world today use high-fructose sweeteners with high-fat foods increases the risk of metabolic syndrome. Fatty organs such as the renal can occur in the metabolic syndrome that causes renal tissue damage. The extract from the Acalypha indica L. plant, a traditional plant from Asia, allegedly has a protective effect against tissue damage to fatty organs such as the liver. This study aims to examine the protective effect of Acalypha indica L. extract on fatty renal in rats. Twenty-five male Sprague Dawley rats were randomly divided into 5 groups. Four treatment groups were induced with high-fructose and fat diet for 4 weeks were then treated with aquadest (control), standard gemfibrozil drug, Acalypha indica L. extract, and a combination of both drugs in each group for 4 weeks. The variables measured were the circumference of the glomerulus, tubular circumference, and tubular diameter of the renal. Significant differences (p < 0.05; 95% CI) were only found in tubular circumferential variables between rats with Acalypha indica L. therapy (146.02±3.46) and control (169.36±18.74) groups. However, combination of gemfibrozil and Acalypha indica L. extract was shown to share similar characteristics with the control (162.34±7.77 vs 169.36±18.74) group. This study indicates that protection effect of Acalypha indica L. extract was better than combination of Acalypha indica L. extract and gemfibrozil on fatty renal in rats.

1.
Goran
MI
,
Ulijaszek
SJ
,
Ventura
EE
.
Glob Public Health.
8
(
1
),
55
64
(
2013
).
2.
Malik
VS
,
Hu
FB
.
J Am Coll Cardiol.
66
(
14
),
1615
1624
(
2015
).
3.
Kelishadi
R
,
Mansourian
M
,
Heidari-Beni
M.
Nutrition.
30
(
5
),
503
510
(
2014
).
4.
Tappy
L
,
KA
,
Tran
C
,
Paquot
N.
Nutrition.
26
(
11–12
),
1044
1049
(
2010
).
5.
de Castro
UGM
,
dos Santos
RAS
,
Silva
ME
,
de Lima
WG
,
Campagnole-Santos
MJ
,
Alzamora
AC
.
Lipids Health Dis.
12
,
136
(
2013
).
6.
Kanwar
P
,
Kowdley
KV
.
Clin Liver Dis.
20
(
2
),
225
243
(
2016
).
7.
Bizino
MB
,
Sala
ML
,
de Heer
P
,
van der Tol
P
,
Smit
JWA
,
Webb
AG
,
de Roos
A
,
Lamb
HJ
.
Magn Reson Imaging Clin N Am.
23
(
1
),
41
58
(
2015
).
8.
Ming
J
,
Xu
S
,
Yang
C
,
Gao
B
,
Wan
Y
,
Xing
Y
,
Zhang
L
,
Yang
W
,
Ji
Q
,
China National Diabetes and Metabolic Disorders Study Group
.
Clin Chim Acta.
430
,
115
120
(
2014
).
9.
Guebre-Egziabher
F
,
Alix
PM
,
Koppe
L
,
Pelletier
CC
,
Kalbacher
E
,
Fouque
D
,
Soulage
CO
.
Biochimie.
95
(
11
),
1971
1979
(
2013
).
10.
Leth
PM
.
J Forensic Radiol Imaging.
5
,
56
58
(
2016
).
11.
de Vries
APJ
,
Ruggenenti
P
,
Ruan
XZ
,
Praga
M
,
Cruzado
JM
,
Bajema
IM
,
D’Agati
VD
,
Lamb
HJ
,
Pongrac Barlovic
D
,
Hojs
R
,
Abbate
M
,
Rodriquez
R
,
Mogensen
CE
,
Porrini
E
,
ERA-EDTA Working Group Diabesity
.
Lancet Diabetes Endocrinol.
2
(
5
),
417
426
(
2014
).
12.
Foster
MC
,
Hwang
S-J
,
Porter
SA
,
Massaro
JM
,
Hoffmann
U
,
Fox
CS
.
Hypertension.
58
(
5
),
784
790
(
2011
).
13.
Rallidis
LS
,
Fountoulaki
K
,
Anastasiou-Nana
M.
Int J Cardiol.
159
(
3
),
169
176
(
2012
).
14.
Malloy
MJ
,
Kane
JP
, “Agents used in dyslipidemia” in
Katzung
B
,
Masters
S
,
Trevor
A.
Basic and clinical pharmacology 12/E
(
McGraw Hill
,
New York
,
2012
), pp.
628
630
.
16.
Seebaluck
R
,
Gurib-Fakim
A
,
Mahomoodally
F.
J Ethnopharmacol.
159
,
137
157
(
2015
).
17.
Krishnaraj
C
,
Muthukumaran
P
,
Ramachandran
R
,
Balakumaran
MD
,
Kalaichelvan
PT
.
Biotechnol Rep.
4
,
42
49
(
2014
).
18.
Dwijayanti
A
,
Frethernety
A
,
Hardiany
NS
,
Purwaningsih
EH
.
Procedia Chem.
14
,
11
14
(
2015
).
19.
Goujon
JM
,
Hauet
T
,
Menet
E
,
Levillain
P
,
Babin
P
,
Carretier
M.
J Surg Res.
82
(
2
),
228
233
(
1999
).
20.
Paller
MS
,
Hoidal
JR
,
Ferris
TF
.
J Clin Invest.
74
(
4
),
1156
1164
(
1984
).
This content is only available via PDF.
You do not currently have access to this content.